Dechra Pharmaceuticals Share Price (DPH)

852.00 -0.50 (-0.06%) delayed: 11:48AM GMT
Bid price 850.00 Open price 848.00
Ask price 854.00 Prev close 852.50
High price 857.00 Spread 0.47%
Low price 848.00 Volume 4,444

Register now for FREE live Dechra Pharmaceuticals share prices, Dechra Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Dechra Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Dechra Pharmaceuticals (DPH) and other London Stock Exchange equities.

Dechra Pharmaceuticals Share Price Chart

Advanced Charts >>

Register now for FREE Dechra Pharmaceuticals share price charts

Dechra Pharmaceuticals Share Price Information

Name Dechra Pharmaceuticals Epic DPH
Sector Pharmaceuticals & Biotechnology ISIN GB0009633180
Activites Dechra Pharmaceuticals plc is an international veterinary pharmaceutical business. Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. Index FTSE 250

Dechra Pharmaceuticals Key Numbers

Latest Share Price (p) 852.00 Net Gearing (%) 23.01
Market Capitalisation (£m) 747.98 Gross Gearing (%) 31.91
Shares in issue (m) 87.95 Debt Ratio 22.73
P/E Ratio 12.59 Debt-to-Equity Ratio 0.63
Total dividends per share (p) 15.40 Assets / Equity Ratio 1.47
Dividend Yield (%) 1.81 Price to book value 3.65
Dividend cover (x) 1.25 ROCE 0.09
Earning per share (p) 67.57 EPS Growth (%) 228.17
52 week high / low 872.50 / 655.00 DPS Growth (%) 10.00

Dechra Pharmaceuticals Director Deals

Dec.Date Type Director Pos No. of Shares
12/09/2014 EXR Ian Page CEO 92,811
12/09/2014 SEXR Ian Page CEO 43,753
03/03/2014 EXR Ian Page CEO 78,656
03/03/2014 SEXR Ian Page CEO 37,080
03/12/2013 EXR Ian Page CEO 5,316

More Dechra Pharmaceuticals Director Deals >>

Dechra Pharmaceuticals Company News

08:20 14/01/2015

Dechra maintains momentum

Dechra Pharmaceutical's trading in the first half of its 2015 financial year was in line with management expectations for both revenue and operating profit. Group revenue increased by approximately 12% at constant currency (6% reported). This was against a soft comparator period in the prior...

07:21 14/01/2015

FLASH: Dechra on track

Story provided by StockMarketWire.com

07:00 14/01/2015

Trading Update and Notice of HY results

/* */ RNS Number : 0908C Dechra Pharmaceuticals PLC 14 January 2015           Wednesday, 14 January 2015   Dechra ® Pharmaceuticals PLC (Dechra or the Group)   Trading Update   The Board...

More Dechra Pharmaceuticals Company News >>

Register now for FREE Dechra Pharmaceuticals company news

Dechra Pharmaceuticals Share Price Discussions

more than 1 year ago

A really dreary share (DPH)

A really dreary share! Dechra Pharmaceuticals manufactures and distributes vetinary products and equiptment.Has a few own brands:- Equipalazone,Vetoryl and Felimazole -anyone used them? My stockbroker molested me so much over this company that I finally bought at 130p,(Feb 04); now at 182.5p...

Register now for FREE Dechra Pharmaceuticals share price discussions